Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis
Nature Medicine2006Vol. 12(9), pp. 1056–1064
Citations Over TimeTop 1% of 2006 papers
Adriano G. Rossi, Deborah A. Sawatzky, Annemieke Walker, Carol Ward, Tara A. Sheldrake, Nicola A. Riley, Alison Caldicott, Magdalena Martínez‐Losa, Trevor R. Walker, Rodger Duffin, Mohini Gray, Elvira Crescenzi, Morag Martin, Hugh J.M. Brady, John Savill, Ian Dransfield, Christopher Haslett
Related Papers
- → Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors(2015)340 cited
- Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein.(1996)
- → Drugging Cell Cycle Kinases in Cancer Therapy(2005)85 cited
- → Differential expression of cyclin-dependent kinases in the adult human retina in relation to CDK inhibitor retinotoxicity(2019)8 cited
- → Cyclin-Dependent Kinase Inhibitor Gene(2020)1 cited